MALT Lymphoma prognosis (MALT-IPI)

Estimate prognosis in MALT lymphoma

The global unit selector only affects unanswered questions
Created by

1. Age?

Created by
0/3 completed

About this Calculator

The MALT-IPI prognostic index was developed using a database of patients treated in an international randomized trial IELSG-19 (n=401) treated with chlorambucil, rituximab, or both. The index was subsequently validated by merging three independent cohorts of MALT lymphoma patients (including 633 patients).

The score is based on 3 simple clinical parameters that were able to discriminate patient prognosis into 3 risk groups (low, intermediate, and high) predictive for event-free and overall survival. The score was also able to discriminate prognosis for patients with gastric or non-gastric MALT lymphoma.


Thielblemont, et al.

A MALT lymphoma prognostic index.

Blood 2017 September 21, 130 (12): 1409-1417

Legal Notices and Disclaimer

© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.